Author

E. Rangelova

Institutions: Sahlgrenska University Hospital, University of Gothenburg

Observed institutions: Sahlgrenska University Hospital, University of Gothenburg

OpenAlex ID: A5159553903

Preventing Complications in High-risk Patients Undergoing Pancreatoduodenectomy with a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA): An International Randomized Trial

2026 · S.R.J. Bosscha, T.E. Hendriks, et al. · HPB

Survival Outcomes after Left Pancreatectomy with or without Splenectomy for Left-sided Pancreatic Ductal Adenocarcinoma: An International Observational Multicenter Study

2026 · M.I. Malakhovskaya, C.L. Bruna, et al. · HPB

Benefit of Adjuvant Chemotherapy for Resected Pancreatic Cancer Following Neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: A Multinational Analysis

2026 · V. Lopez Lopez, T. Hasse, et al. · HPB

Impact of Surgical Resection on Survival in Patients with Suboptimal CA19-9 Response Following Neoadjuvant Therapy for Pancreatic Cancer

2026 · M. Hamed, O. Blomqvist, et al. · HPB

Works count: 4

Citation count:

H-index:

I10-index: